Product Information

PROPYLTHIOURACIL 50 MG TABLET is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.2829 per EA under NDC 33342031411. Its NADAC has been published 138 times since Apr 3, 2024.

FDA first approved this application on May 10, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PROPYLTHIOURACIL 50 MG TABLET

Propylthiouracil
$0.2829per EA

Strength

50 mg/1

NDC

33342031411

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

PROPYLTHIOURACIL

Approval Type

Generic (ANDA)

FDA Application

ANDA208867

FDA Approved

5/10/2023

TE Code

AB

On Market Since

5/10/2023

Pharmacological Classes

Thyroid Hormone Synthesis Inhibitor
Thyroid Hormone Synthesis Inhibitors

Price Statistics

The NADAC for PROPYLTHIOURACIL 50 MG TABLET has been published 138 times since Apr 3, 2024, and over the history we have for it it has declined 27.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2829 per EA
All-time high$0.3875 (Apr 10, 2024)
All-time low$0.2149 (May 22, 2024)
52-week high$0.2847
52-week low$0.2646
Median price$0.2806
Average price$0.2858
Largest weekly change-44.1% (May 22, 2024)
Weeks tracked138
Tracking sinceApr 3, 2024

Price History

1W

+5.0%

1M

+5.3%

3M

+4.7%

6M

-0.7%

1Y

-2.4%

3Y

N/A

5Y

N/A

All

-27.0%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of PROPYLTHIOURACIL 50 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PROPYLTHIOURACIL 50 MG TABLET, manufactured by Macleods Pharmaceuticals Limited, is $0.2829 per EA (NDC 33342031411), effective Nov 18, 2026.

How has the price of PROPYLTHIOURACIL 50 MG TABLET changed over time?

Over the history we have for it, the NADAC for PROPYLTHIOURACIL 50 MG TABLET has declined 27.0%. It has been tracked across 138 weekly CMS publications since Apr 3, 2024.

What are the highest and lowest recorded NADAC prices for PROPYLTHIOURACIL 50 MG TABLET?

Since Apr 3, 2024, the NADAC for PROPYLTHIOURACIL 50 MG TABLET has ranged from a low of $0.2149 (May 22, 2024) to a high of $0.3875 (Apr 10, 2024), with a median of $0.2806 per EA.

Are there cheaper alternatives to PROPYLTHIOURACIL 50 MG TABLET?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PROPYLTHIOURACIL 50 MG TABLET, is $0.2724 per EA — about 4% below PROPYLTHIOURACIL 50 MG TABLET.

Who manufactures PROPYLTHIOURACIL 50 MG TABLET?

PROPYLTHIOURACIL 50 MG TABLET (NDC 33342031411) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.